Liraglutide, a GLP-1 agonist, as a new adjunct treatment in Hailey-Hailey disease, a case report
857,858 Single-cell RNA sequencing analysis revealed a new subgroup of inflammatory chondrocytes with regulatory potential in the microenvironment of hand osteoarthritis
The trial is led by two Chief Investigators, Professor Philip Newsome at Kings College London and Arun Sanyal at the VCU School of Medicine, United States, and funded by Novo Nordisk
Retatrutide is an investigational triple receptor agonist (GLP-1, GIP, glucagon) that remains unlicensed in the UK, with no MHRA approval, no NHS availability, and no BNF listing as of 20242025
Why Choose AV Medical Center
The prolonged stretching of the stomach can also activate the gastrocolic reflexa natural response that increases movement in the colonwhich may further contribute to diarrhea